81 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
JNJ Johnson & Johnson $139.96 $375.48B N/A
Article Searches
JNJ says no asbestos found in baby powder https://seekingalpha.com/news/3523522-jnj-says-no-asbestos-found-in-baby-powder?source=feed_news_all Dec 03, 2019 - Tests conducted by two third-party labs show asbestos was not present in the single bottle that the FDA's contracted lab tested, nor was it present in retained samples of the finished lot from which t
J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders http://www.zacks.com/stock/news/653885/jjs-jnj-new-tests-reveal-no-asbestos-in-baby-powders?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-653885 Dec 04, 2019 - J&J (JNJ) says that two third-party labs conducted 155 tests on samples of its baby powders. All these tests confirm that the talc does not contain asbestos, a known carcinogen.
Dow Jones News: Johnson & Johnson Concludes Asbestos Investigation; Analyst Sees Upside for United Technologies https://www.fool.com/investing/2019/12/04/dow-jones-news-johnson-johnson-concludes-asbestos.aspx?source=iedfolrf0000001 Dec 04, 2019 - J&J's baby powder is asbestos free, and United Technologies stock could rise another 16%.
3 Warren Buffett Dividend Stocks You Can Buy Right Now https://www.fool.com/investing/2019/12/05/3-warren-buffett-dividend-stocks-you-can-buy-right.aspx?source=iedfolrf0000001 Dec 05, 2019 - Get paid like the famous investor with these relatively high-yield payers.
Glaxo Files NDA for Fostemsavir for Heavily Pre-Treated HIV http://www.zacks.com/stock/news/657513/glaxo-files-nda-for-fostemsavir-for-heavily-pre-treated-hiv?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-657513 Dec 06, 2019 - Glaxo (GSK) submits a new drug application to the FDA for its first-in-class attachment inhibitor fostemsavir, which is being evaluated for the treatment of HIV-1 infection.
Amgen Gets FDA Approval for J&J/Merck's Remicade Biosimilar http://www.zacks.com/stock/news/661958/amgen-gets-fda-approval-for-jj-mercks-remicade-biosimilar?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-661958 Dec 09, 2019 - FDA gives nod to Amgen's (AMGN) Avsola (ABP 710), a biosimilar of J&J's blockbuster rheumatoid arthritis drug, Remicade.
2 Healthcare Stocks I’d Buy Right Now https://www.fool.com/investing/2019/12/16/2-healthcare-stocks-id-buy-right-now.aspx?source=iedfolrf0000001 Dec 16, 2019 - These two companies are industry leaders in their respective fields.
JNJ: Barclays ups to Overweight https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=UD20191219073140 Dec 19, 2019 - Barclays issues rating change for JNJ
The Top Biotech Stocks to Watch Following ASH 2019 https://www.fool.com/investing/2019/12/19/the-top-biotech-stocks-to-watch-following-ash-2019.aspx?source=iedfolrf0000001 Dec 19, 2019 - The potential to reshape treatment of blood cancer and disorders could mean big bucks for these companies.
Bet on These 5 Low Leverage Stocks to Invest Judiciously http://www.zacks.com/stock/news/690197/bet-on-these-5-low-leverage-stocks-to-invest-judiciously?cid=CS-ZC-FT-analyst_blog|rw-690197 Dec 27, 2019 - Debt level of a company is an important point of consideration while making an investment decision.

Pages: 123456...9

Page 1>